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2 
Abstract 1 
Silencing of FMR1 and loss of its gene product FMRP results in Fragile X Syndrome. FMRP binds 2 
brain mRNAs and inhibits polypeptide elongation. Using ribosome profiling of the hippocampus, 3 
we find that ribosome footprint levels in Fmr1-deficient tissue mostly reflect changes in RNA 4 
abundance. Profiling over a time course of ribosome runoff in wildtype tissue reveals a wide range 5 
of ribosome translocation rates; on many mRNAs, the ribosomes are stalled. Sucrose gradient 6 
ultracentrifugation of hippocampal slices after ribosome runoff reveals that FMRP co-sediments 7 
with stalled ribosomes; and its loss results in decline of ribosome stalling on specific mRNAs. One 8 
such mRNA encodes SETD2, a lysine methyltransferase that catalyzes H3K36me3. ChIP-Seq 9 
demonstrates that loss of FMRP alters the deployment of this epigenetic mark on chromatin. 10 
H3K36me3 is associated with alternative pre-RNA processing, which we find occurs in an FMRP-11 
dependent manner on transcripts linked to neural function and autism spectrum disorders.  12 
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3 
Introduction 1 
 2 
The Fragile Syndrome (FXS) is characterized by intellectual disability, developmental delays, 3 
social impairment, hyper-anxiety, and other maladies. The root cause of FXS is an iteration of 4 
~200 or more CGG triplets in FMR1 that induces DNA methylation and transcriptional inactivation. 5 
Loss of the FMR1 gene product FMRP results in synaptic dysfunction and aberrant circuit 6 
formation, which produces neuro-pathological conditions during development (Santoro et al 7 
2012). FXS is modeled in Fmr1 knockout mice, which mimic many facets of the human disease 8 
including learning and memory deficits, repetitive disorders, susceptibility to seizures, etc. In these 9 
animals, neuronal communication is frequently examined at hippocampal Schaffer collateral-CA1 10 
synapses, which exhibit exaggerated metabotropic glutamate receptor-dependent long term 11 
depression (mGluR-LTD) (Huber et al 2002). This form of synaptic plasticity normally requires 12 
protein synthesis but in Fmr1-deficient animals, protein synthesis is both unnecessary for mGluR-13 
LTD and excessive in neurons, which contributes to aberrant circuit formation and other hallmarks 14 
of the syndrome (Waung and Huber 2009). 15 
 FMRP is an RNA binding protein present in most cells; in neurons, its localization at 16 
postsynaptic sites is thought to control activity-dependent synapse remodeling by regulating 17 
mRNA expression (Richter et al 2015). Considerable effort has been made to identify FMRP 18 
target mRNAs but the most rigorous involves in vivo crosslink and immunoprecipitation (CLIP). 19 
CLIP combined with RNA-seq has identified 842 target mRNAs in the p11-p25 mouse cortex and 20 
cerebellum (Darnell et al 2011), predominantly a single mRNA in cultured cortical neurons (Tabet 21 
et al 2016), 1610 RNAs in the p13 cortex, hippocampus, and cerebellum (Maurin et al 2018), and 22 
~6000 RNAs in HEK cells ectopically expressing epitope-tagged FMRP (Ascano et al 2012). This 23 
diversity of FMRP CLIP targets could reflect the different procedures employed or the different 24 
brain cell types examined. Surprisingly, the majority of CLIP sites in mRNA are in coding regions 25 
(Darnell et al 2011; Maurin et al 2018), with perhaps a bias to some cis sequences (Anderson et 26 
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4 
al 2016; Maurin et al 2018). FMRP association with mRNA coding regions and co-sedimentation 1 
with polyribosomes in sucrose gradients (Khandjian et al 1996; Feng et al 1997; Stefani et al 2 
2004) suggests that it normally inhibits translation by impeding ribosome translocation. Indeed, 3 
studies that examined polypeptide elongation directly (Udagawa et al 2013) or susceptibility to 4 
puromycin release of nascent polypeptides (Darnell et al 2011) indicate that FMRP regulates 5 
translation at the level of ribosome transit. Supporting evidence comes from studies showing that 6 
Drosophila FMRP interacts with ribosomal protein L5 (rpL5) (Ishizuka et al 2002), which may 7 
preclude tRNA or elongation factors from engaging the ribosome, thereby leading to a stalled 8 
configuration (Chen et al 2014). Although these observations need to be extended to mammalian 9 
FMRP, they suggest a molecular mechanism by which FMRP stalls ribosomes. However, such 10 
observations do not indicate whether or how FMRP could stall ribosomes on specific mRNAs. 11 
 Ribosome profiling is a whole genome method for analyzing the number and positions of 12 
ribosomes associated with mRNA; when combined with RNA-seq, it yields valuable and 13 
heretofore unobtainable information on gene expression at high resolution (Ingolia et al 2009; 14 
Ingolia 2014; Brar and Weismann 2015). We have used this method to explore FMRP regulation 15 
of gene expression in mouse adult neural stems cells (aNSCs), which in FXS have an abnormal 16 
proclivity to differentiate into glia at the expense of neurons (Luo et al 2010; Guo 2011). We 17 
identified hundreds of mRNAs whose ribosome occupancy was up or down regulated in FMRP-18 
deficient cells, demonstrated that hundreds of other mRNAs had altered steady state levels and 19 
whose ribosome association reflected these alterations, and discovered yet additional mRNAs 20 
whose ribosome occupancy was “buffered” so that changes in their levels was compensated for 21 
by opposite changes in ribosome association (Liu et al 2018). 22 
 Ribosome profiling at steady state cannot distinguish between translocating and stalled 23 
ribosomes, suggesting that studies examining FMRP-regulated translation by this method or ribo-24 
TRAP (Thomson et al 2017; Liu et al 2018, 2019; Greenblatt and Spradling 2018; Das Sharma et 25 
al 2019) may overlook key events leading to FXS. Moreover, if intact brain circuitry is important 26 
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5 
for FMRP regulation, then culturing disaggregated neurons, for example, might not reveal 1 
important aspects of FMRP function. To circumvent these issues, we have developed a 2 
hippocampal slice assay to detect mRNA-specific ribosome translocation dynamics. Hippocampal 3 
slices maintain the in vivo synaptic connectivity and cellular architecture, as well as express 4 
protein synthesis and FMRP-dependent forms of synaptic plasticity (Huber et al., 2002). Profiling 5 
over a time course of ribosome runoff in slices demonstrates a wide range of ribosome 6 
translocation rates on specific mRNAs, ranging from rapid (rates similar to those in ES cells, 7 
Ingolia et al 2011) to near complete stalling. A number of mRNAs retain 4-6 ribosomes after runoff 8 
in WT, but not in FMRP-deficient slices. Some RNAs associated with FMRP-stalled ribosomes 9 
encode proteins involved in neurologic function and transcriptional regulation. One such RNA 10 
encodes an epigenetic regulator, SETD2, a methyltransferase for the chromatin mark H3K36me3. 11 
We find an increase in SETD2 protein levels in Fmr1-deficient hippocampus. ChIP-seq 12 
demonstrates that distribution of this mark varies in a genotype (i.e, WT vs. Fmr1-deficient)-13 
dependent manner in hippocampal tissue. In mammals, apart from blocking cryptic transcription 14 
initiation and DNA damage response, H3K36me3 is correlated with pre-mRNA processing events 15 
such as alternative splicing (Kim et al 2011; Kolasinska-Zwierz et al 2009). RNA sequencing 16 
reveals that a number of splicing events such as exon skipping are altered in FMRP-deficient 17 
slices, and that these transcripts are linked to neural function and autism spectrum disorders. 18 
Aberrant RNA splicing of synapse related genes has in recent years been found to be widely 19 
prevalent in autism spectrum disorders (Lee et al., 2016; Quesnel-Vallières et al., 2016; Smith 20 
and Sadee, 2011). Our study demonstrates that a reduction in ribosome stalling in the Fmr1-21 
deficient brain results in a cascade of epigenetic and RNA processing changes that likely 22 
contribute to neurologic disease. 23 
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6 
Results 1 
 2 
 Hippocampal Schafer collateral-CA1 synapses exhibit an exaggerated mGluR-LTD in 3 
Fmr1-deficient mice that is aberrantly protein synthesis-independent (Huber et al 2000). To 4 
identify mRNAs whose basal level expression is misregulated, we prepared CA1-enriched 5 
hippocampal slices (400µm thickness) (Figure 1A), performed ribosome profiling and RNA-seq 6 
(Figure 1B) and calculated translational efficiency (TE), which is defined as the number of 7 
ribosome footprints divided by the number of RNA-seq reads. We identified RNAs with changes 8 
in TE (TE up /TE down) or RNAs whose levels were elevated or reduced but without 9 
commensurate changes in TE (mRNA up/ mRNA down) (Figure 1C, Table S1) (nominal p-value< 10 
0.01, false discovery rate = 0.097 by permutation test). A gene ontology (GO) functional analysis 11 
of the biological processes most enriched in each regulatory group shows that the RNA down 12 
group encodes factors that mediate taxis/chemotaxis, while the “mRNA up” group encodes factors 13 
involved in ribonucleotide metabolism (Figure 1D, S1A,B). The “TE down” mRNAs encode factors 14 
that control synaptic transmission (Figure 1D, S1C). The “mRNA down” group is enriched for 15 
cellular components linked to the extracellular matrix while the “mRNA up” group encodes the 16 
myelin sheath and spliceosomal-interacting factors. The “TE down” group is involved in the 17 
extracellular matrix and structures involved in synaptic architecture (Figure 1E, S1C). No GO 18 
terms from the TE up group were statistically significant.  19 
Heat maps of the top 20 mRNAs with altered TEs both up and down in Fmr1-deficient 20 
hippocampal slices compared to the wild type are shown in Figures 2A and B. Examples of the 21 
change in TEs is depicted in Figure 2C. Gfpt2 (glutamine-fructose-6-phosphate transaminase 2) 22 
mRNA, is nearly unchanged in Fmr1 KO but has an increase in ribosome footprints Figure 2C). 23 
Conversely Lhfpl5 (Lipoma HMGIC fusion partner-like 5) mRNA, has reduced numbers of 24 
ribosome footprints while RNA levels are mostly unchanged (Figure 2D). Neither Gfpt2 nor Lhfpl5 25 
mRNAs have FMRP CLIP sites. Figure 2E shows boxplots for all 843 FMRP CLIP RNAs (Darnell 26 
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7 
et al 2011). As a group, these RNAs decrease significantly in Fmr1 KO, which is tracked by 1 
commensurate decreases in ribosome footprints resulting in no change in TE.  2 
We compared our “TE down” and “TE up” groups in Fmr1 KO hippocampus with results 3 
from Das Sharma et al (2019), who performed ribosome profiling on mouse frontal cortex, and 4 
Thomson et al (2017) who performed ribosome affinity purification (TRAP-seq) from hippocampal 5 
CA1 pyramidal neurons (Figure 2F). Only 37 of our TE down RNAs were similarly detected by 6 
Das Sharma et al (2017) and only 5 by Thomson et al (2017). Even fewer of our TE up RNAs 7 
were detected in either of those studies (Figure 2F). We surmise that the differences in methods 8 
and source material are likely responsible for little overlap among the studies. 9 
Our data show almost all changes in ribosome footprint number in Fmr1-deficient 10 
hippocampal-cortical slices can be attributed to altered RNA levels irrespective of whether the 11 
transcripts are FMRP CLIP targets. This suggests that the increase in incorporation of labeled 12 
amino acids into protein in Fmr1 KO hippocampal slices (e.g., Dolen et al 2007; Udagawa et al 13 
2103; Bowling et al 2019) is mostly due to changes in RNA levels and/or ribosomal transit rate 14 
(see below). However, TE may not necessarily reflect protein production. For example, increased 15 
initiation with no change in elongation would result in an increased density of ribosome footprints 16 
and yield an elevated level of protein product (Figure 2G). If there is no change in initiation but 17 
elevated elongation, the TE will appear to be reduced but the production of protein will be 18 
increased. Consequently, ribosome profiling at steady state, which cannot distinguish between 19 
transiting and stalled ribosomes, may inadequately represent translation if there are changes in 20 
elongation. To assess whether FMRP regulates ribosome dynamics, we modified our procedure 21 
to investigate temporal changes in genome-wide ribosome translocation rates. 22 
  23 
Ribosome run off dynamics in hippocampal-cortical slices 24 
 We next performed ribosomal profiling and RNA-seq in hippocampal-cortical slices at 25 
different time points after blocking initiation with homoharringtonine (HHT). HHT halts ribosomes 26 
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8 
on initiation codons but allows elongating ribosomes to continue translocating until they run off 1 
the mRNA (Ingolia et al 2012; Lee et al 2012). Using this assay, we aimed to determine 2 
differences in ribosome translocation rates of all expressed genes in wild type tissue slices. Slices 3 
were incubated with HHT for 0-60 min and ribosome transit stopped at specific times with 4 
cycloheximide; the samples were then used for ribosome profiling (Figure 3A, Table S1). A 5 
metagene analysis of the ribosome footprints on 1401 mRNAs with open reading frames of >3000 6 
nt aligned with the start and stop codons is shown in Figure 3B. The read densities at each 7 
position were normalized to the average densities of the last 500 nucleotides of the CDS and is 8 
based on the P site of the ribosome footprints. Using these data, a linear regression analysis 9 
between the HHT treatment time and ribosome runoff distances was used to estimate the global 10 
elongation rate of 4.2 nt/sec at 30oC (Figure 3C). By comparison, the global elongation rate in 11 
cultured ES calls is 1.7 nt/sec at 37oC (Ingolia et al 2011). 12 
 We next performed a cluster analysis of all the RNAs with respect to number of ribosome 13 
protected fragments at each time point (5, 10, 30, 60 min) relative to time 0. Briefly, euclidean 14 
distance was first computed, followed by hierarchical clustering using Ward’s algorithm (Ward, 15 
1963), and the Analysis of group similarities (ANOSIM) test (Clarke, 1993) was then used to 16 
assess whether distances between clusters were statistically greater than within clusters (Figure 17 
3D). The RNAs fell into two broad clusters (ANOSIM R=0.56, p-value<0.001): those whose 18 
ribosome runoff occurred relatively quickly (i.e., within 5-10 min, bottom cluster), and those whose 19 
runoff occurred slowly, if at all (top cluster). These two clusters were then further grouped into 3 20 
sub-clusters each for 6 total sub-clusters (ANOSIM R=0.64, p-value<0.001). Sub-clusters 1-3 had 21 
slow runoff times while sub-clusters 4-6 had relatively fast ribosome runoff times (Figure 3D and 22 
3E). The ribosomes on RNAs in sub-cluster 2 had the slowest runoff time. We next determined 23 
the ribosome runoff patterns for the RNAs in each sub-cluster (Figure 3E). For example, RNAs 24 
for Alcam (activated leukocyte cell adhesion molecule), Arc (activity-regulated cytoskeleton), and 25 
Nptn (neuroplastin) are present in the sub-cluster 1, Col11 (collectin subfamily 11) in sub-cluster 26 
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9 
2, Nrxn3 (neurexin 3) in sub-cluster 3 and actin in sub-cluster 4 (Figure 3F). As examples, Figure 1 
3G shows the ribosome footprints of Nrxn3 and actin over time; Figure S2A shows ribosome 2 
footprints for additional RNAs. Although there was some CDS length dependency of the ribosome 3 
runoff rates, the correlation was not linear (Figure S2B). GO term analysis showed that specific 4 
biological activities were remarkably associated with each sub-cluster. Genes in sub-clusters 1 5 
and 3 were closely associated with neural function such as axon development and synapse 6 
organization (Figure 3H). Sub-cluster 2, which contained ribosomes with the slowest runoff rates, 7 
had genes encoding the extracellular matrix, sub-cluster 4 contained genes involved in metabolic 8 
functions, sub-cluster 5 was associated with RNA processing and regulation, and sub-cluster 6 9 
with organelle localization, among other functions (Figure S2C). These results suggest that 10 
clusters of mRNAs with specific functions have differential ribosomal transit rates. 11 
 12 
FMRP controls ribosome translocation on specific mRNAs 13 
 To investigate whether FMRP controls ribosome stalling on specific mRNAs, we first 14 
determined whether it is present in ribosome-containing complexes or “granules” as suggested 15 
by earlier studies (Feng et al 1998; Khandjian et al 2004; Stefani et al 2004; El Fatimy et al 2016). 16 
Extracts from cortices were treated with nonionic (NP40) or ionic (DOC) detergents, or RNase 17 
and sedimented through sucrose gradients. Figure S3A shows FMRP sedimented to a “heavy” 18 
ribosome-containing region of the gradient even in the presence of NP40 or RNase; DOC 19 
treatment, however, stripped FMRP from ribosome-containing complexes as shown previously 20 
(Stefani et al 2004; Darnell et al 2011). These data suggest that FMRP is associated with 21 
ribosomes in heavy granule structures and thus could play a role in ribosome stalling. 22 
We next performed sucrose gradient analysis of hippocampal slices treated with HHT for 23 
30 min (Figure 4), which allows ribosomes on most genes to run off (as shown in Figure 3). Figure 24 
4A shows that most FMRP co-sediments with polysomes as has been shown previously (e.g., 25 
Feng et al 1998; Stefani et al 2004), but after HHT treatment, it is more prevalent in “medium” 26 
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10 
gradient fractions that correspond to 4-6 ribosomes. Other proteins (e.g., UPF1, MAP2, eEF2) do 1 
not show a similar change in sedimentation (Figure S3B).  A small amount of FMRP remains in a 2 
“heavy” (>7 ribosomes) region of the gradient (Figure 4B). The same experiments were performed 3 
with Fmr1 KO slices (Figure 4C, D). RNA-seq of the “heavy” fractions showed that 1574 RNAs 4 
and 686 RNAs were reduced or elevated, respectively, in both genotypes, indicating that heavy 5 
granules contain mRNAs that are sensitive or resistant to HHT treatment (Figure 4E). Actin is one 6 
such RNA that was sensitive to HHT that was depleted by ribosome runoff (Figure 4F), which is 7 
consistent with results from the HHT time course (Figure 3F, G). Map1b RNA, on the other hand, 8 
was enriched in the heavy polysomes by HHT treatment (Figure 4G). Figure 4H shows GO terms 9 
for the RNAs depleted in the heavy fractions after runoff, which include RNA processing and other 10 
factors involved in RNA metabolism. Figure 4I shows the GO terms for RNAs enriched in the 11 
heavy polysomes after HHT treatment, which include factors involved in membrane and ion 12 
transport. 13 
In contrast to the “heavy” polysome fractions, we found genotype-specific differences in 14 
the RNA-seq of the “medium” polysome fractions (Table S1). Forty-six RNAs were down-15 
regulated in HHT-treated Fmr1 KO slices relative to WT, indicating that they are normally bound 16 
by FMRP-stalled ribosomes (Figure 5A). Eight of these mRNAs encode epigenetic and 17 
transcriptional regulators and 23 encode proteins specifically involved in neural function (Figure 18 
5B). One example is Ankrd12 (ankyrin repeat domain containing 12), which is depleted in the KO 19 
slices following HHT treatment (Figure 5C). Figure 5C shows that after HHT treatment, Ankrd12 20 
RNA contains fewer stalled ribosomes in the medium fractions of Fmr1 KO slices, confirming this 21 
mRNA is under FMRP regulation. Figure 5D demonstrates that compared to all RNAs, the HHT-22 
sensitive RNAs (Figure 5B) showed significant decreases in RPFs and TEs but not RNA levels in 23 
Fmr1 KO relative to WT (ribosome profiling data of these RNAs from Figure 2) showing the 24 
consistency between steady state ribosome profiling and the dynamic ribosome run-off assay. 25 
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11 
Finally, Figure 5E demonstrates that one of the mRNAs decreased in the “medium” 1 
fraction in the  Fmr1 KO slices, SETD2, shows an increase in its protein levels in Fmr1 KO 2 
hippocampus relative to WT, which is expected if FMRP stalls ribosome translocation on this 3 
RNA. SETD2 is the sole histone lysine methyltransferase that trimethylates the histone H3 tail on 4 
the lysine36(K36) residue.  5 
 6 
FMRP mediated regulation of H3K36me3 7 
 To investigate whether altered SETD2 levels influence gene-specific changes in 8 
H3K36me3, we performed ChIP-seq from WT and Fmr1 KO hippocampus in duplicate, combining 9 
hippocampal tissue from 2 animals per biologic replicate (Figure 6A). All genotypic replicates were 10 
highly correlated with each other (Figure S4A). H3K36me3 is a broad histone mark that is 11 
enriched primarily in the body of the gene. To measure regions with enrichment of the mark we 12 
used the SICER v1.1 package (Xu et al., 2014) that annotates ChIP signal over a stretch of DNA 13 
as ‘islands’ (an island is defined as a cluster of non-overlapping consecutive DNA regions (200 14 
bp windows) separated by at least a 600bp gap region of DNA with no ChIP-enriched signal 15 
detected above threshold). Annotation of the H3K36me3 islands shows that they were primarily 16 
present within the gene body compared to promoter proximal regions, as expected (Krogan et al 17 
2003; Tiedemann et al 2016) (Figure 6B,I). Metagene analysis showed there to be no genotype-18 
specific difference in the distribution of marks overall along the gene body and no effect of gene 19 
length (Figure S4B, C, D). Next, we compared the number of genes with H3K36me3 islands 20 
detected between both genotypes, and found more H3K36me3 harbouring genes in the Fmr1 KO 21 
than those in the WT (Figure 6B, II; note that there may be multiple islands in a single gene). We 22 
further compared the differential enrichment of the H3K36me3 islands between the genotypes 23 
using SICER-df script from the SICER v1.1 package (Xu et al., 2014). We found 3008 islands with 24 
decreased and 2472 islands with increased H3K36me3 in the Fmr1 KO compared to wild type 25 
hippocampus ChIP-seq (p-value < 0.0001, FDR <0.0001) (Table S2). Examples of the changes 26 
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12 
of these marks that are genotype-dependent is shown in Figure 6C where H3K36me3 on Reep4 1 
(receptor expression-enhancing protein 4) is reduced but elevated on Tprkb (TP53-related protein 2 
kiase binding protein). The decreased islands were mostly found in intragenic regions whereas 3 
the increased islands were present in higher proportion in the intergenic regions (Figure 6D) 4 
demonstrating a redistribution of H3K36me3 in FXS model mice. Many of the islands, especially 5 
those that decrease in Fmr1 KO animals are found on genes linked to autism spectrum disorders 6 
as defined by SFARI (Figure 6E). A subset of genes (219) showed both increased and decreased 7 
islands along the length of the gene body (Figure 6E). GO term enrichment analysis of the genes 8 
that have either increased or decreased H3K36me3 islands is shown in Figure 6F. Although the 9 
genes that have decreased islands are quite diverse, those with increased islands are remarkably 10 
enriched for genes involved in neural function such as synapse assembly and animal behavior. 11 
The methylated islands also undergo genotype-specific length changes; they are significantly 12 
longer in the WT compared to Fmr1 KO (p-value <0.001, Kolmogorov-Smirnov (KS) test) (Figure 13 
S4E). Our data thus show that an increase in the levels of SETD2 in the Fmr1 KO results in 14 
dysregulated H3K36me3 chromatin marks.  15 
 16 
FMRP regulates alternative RNA processing 17 
 H3K36me3 in mammals has been correlated with alternative pre-mRNA splicing (Kim et 18 
al 2011). We analyzed our RNA-seq data from WT and Fmr1 KO hippocampal slices using rMATS 19 
alternative splicing package (Shen et al., 2014) and detected many alternative pre-mRNA 20 
processing events including skipped exon (SE), mutually excluded exon (MXE), alternative 5’ and 21 
3 splice site (A5SS and A3SS), as well as retained intron (RI) (Figure 7A, Table S3, FDR < 5% 22 
and p-value<0.05). The number of exon inclusion events are shown (Differences in exon inclusion 23 
levels is calculated as Percent Spliced In (PSI) and a cutoff of |deltaPSI| ≥ 5% is used). Several 24 
of the exon skipping events were validated by RT-qPCR, with ~20-40% reduction in exon skipping 25 
in the Fmr1 KO relative to WT (Figure 7B). These skipped exons have previously been found to 26 
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13 
be associated with defects in brain development and disease pathology (An and Grabowski, 2007; 1 
Fugier et al., 2011; Rockenstein et al., 1995; Wang et al., 2018). Figure 7C shows all the RNA 2 
processing events that undergo changes in Fmr1-deficient hippocampus relative to WT (p-3 
value<0.05, |deltaPSI| ≥ 5%). Skipped exons are by far the most prevalent category, followed by 4 
alternative 3’ splice sites; retained introns are the most infrequent. The genes whose RNA 5 
processing events are altered in Fmr1 KO are strongly linked to neural function such as vesicle 6 
transport to synapses, vesicle recycling, etc. (Figure 7D). Moreover, many of the alternatively 7 
spliced (Alt. Spl. or AS) genes in Fmr1 KO hippocampus (Alt. Spl. Fmr1 KO) are linked to autism 8 
(i.e., SFARI autism spectrum disorder database, ASD) (Figure 7E). In addition, the AS genes in 9 
Fmr1 KO significantly overlap with genes previously found to be alternatively spliced in patients 10 
with autism (Alt. Spl. ASD) (Parikshak et al., 2016) (Figure 7E). We also find an overlap of genes 11 
with changes in H3K36me3 islands with those found to harbor aberrant splicing in Fmr1 KO tissue 12 
(Figure 7E). We next assessed the H3K36me3 levels at the skipped exons in the SE category 13 
and found a trend towards a decrease in the H3K36me3 marks at the 5’ splice site of these exons 14 
that are skipped in the Fmr1 KO hippocampus compared to the wild type (Figure 7F, p-15 
value<0.07). Thus, as with other autism spectrum disorders, dysregulated alternative splicing is 16 
prevalent in a mouse model of FXS and might be linked to changes in H3K36me3.  17 
 18 
  19 
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14 
Discussion 1 
 2 
 We used several approaches to investigate FMRP regulation of mRNA expression in the 3 
mouse brain, focusing first on steady state ribosome profiling in hippocampal slices. Fmr1 4 
deficiency resulted in ribosome footprint levels that mostly tracked altered levels of RNA, which 5 
is consistent with other studies (Liu et al 2018; 2019; Das Sharma et al 2019). Because ribosome 6 
profiling at steady state cannot distinguish between static and translocating ribosomes, we 7 
modified our profiling procedure (Ingolia et al 2011) to identify the dynamic range of ribosome 8 
translocation rates genome-wide in hippocampal slices. These studies in turn resulted in four 9 
main novel findings. First, they showed that mRNAs cluster into defined functional biology groups 10 
based on the transit rates of their associated ribosomes. The ribosomes on most (>5000 11 
detectable mRNAs) transit relatively rapidly, whereas on other RNAs (~3000), ribosome transit is 12 
slow or nearly not at all (~350). There is some CDS length dependency as well. Second, using a 13 
combination of ribosome runoff and sucrose gradient centrifugation, we identified ~50 mRNAs 14 
associated with FMRP-stalled ribosomes, which strongly imply translational regulation. One of 15 
these mRNAs encodes a histone lysine methyltransferase, SETD2, which is elevated in Fmr1 KO 16 
hippocampus. Third, the SETD2-dependent histone mark, H3K36me3, is rearranged in both 17 
intragenic and intergenic regions upon Fmr1 deficiency. Fourth, because H3K36me3 has been 18 
correlated with alternative RNA processing in mammals (Kim et al 2011), we analyzed our RNA-19 
seq data and found widespread aberrant splicing in the Fmr1 KO hippocampus, most prominently 20 
exon skipping/inclusion. These altered processing events often correlated with changes in the 21 
histone mark, occurred on genes that regulate pre-synaptic functions such as synaptic vesicle 22 
recycling, and were strongly linked to autism spectrum disorders (Figure 7E).  23 
 Earlier studies have inferred that ribosome stalling in the brain is linked to RNA transport 24 
granules in dendrites (Krichevsky and Kosik 2001; Mallardo et al 2003; Kanai et al 2004; 25 
Khandjian et al 2004). It is possible that at least some of the ribosome stalling we observe may 26 
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15 
be the result from such compartmentalization in neurons, or perhaps is a more general feature of 1 
the brain. In contrast, rapidly dividing ES cells do not appear to have stalled ribosomes, at least 2 
not of the magnitude we observe here (Ingolia et al 2011). Irrespective of whether ribosome 3 
stalling is a dendritic or neuronal phenomenon, how it occurs mechanistically on specific mRNAs 4 
is unclear, but it could be related to secondary structure or association with RNA binding or other 5 
proteins. One clue, however, could be the accumulating evidence that strongly implicates 6 
phosphorylation of eEF2 as a coordinator of translation and neural activity, and thus is likely to be 7 
one mediator of ribosome translocation rates (Scheetz et al 2000; Sutton et al 2007; Park et al 8 
2008; McCamphill et al 2015; Heise et al 2017). Even so, the involvement of phospho-eEF2, a 9 
general translation factor, would unlikely be responsible for mRNA-specific stalling. We also noted 10 
that some mRNAs, such as those in sub-cluster 2 (Figure 3D, E) encode proteins involved in the 11 
extracellular matrix (Figure S2C). A number of these proteins contain proline-rich stretches, 12 
whose geometry in the polypeptide exit tunnel can lead to ribosome stalling (Schuller et al 2017; 13 
Hutter et al 2017). 14 
 We have identified ~50 mRNA whose ribosomes are stalled specifically by FMRP. These 15 
RNAs include those with and without FMRP CLIP sites in coding regions, so it would appear that 16 
a simple FMRP “roadblock” model would not explain ribosome stalling. Alternatively, Ishizuka et 17 
al (2002) showed that Drosophila FMRP binds ribosomal proteins, and in a cryo-EM study, Chen 18 
et al (2014) found that Drosophila FMRP reconstituted with mammalian ribosomes binds a region 19 
that would preclude tRNA and elongation factors from engaging in translation. However attractive 20 
this model is for FMRP-mediated ribosome stalling, the fact that mRNA or translation factors were 21 
not included in the reconstitution assays brings into question whether it reflects the physiological 22 
basis for ribosome stalling. 23 
 Our studies revealed that FMRP stalls ribosomes on a number of mRNAs that encode 24 
epigenetic regulators and that the mis-regulation of one of them in Fmr1-deficient hippocampus, 25 
SETD2, leads to widespread changes in H3K36me3 chromatin marks (islands). These 26 
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16 
H3K36me3 islands are both enriched for and depleted from autism risk genes (Figure 6E) as well 1 
as those with synaptic functions (Figure 6F). This suggests that SETD2, the only enzyme that 2 
catalyzes this chromatin mark, might also be an autism risk gene, which has been previously 3 
reported (Lumish et al 2015). Mutations in several chromatin remodeling genes have been linked 4 
to changes in neural function, autism, and other intellectual disabilities (van Bokhoven 2011; 5 
Goodman and Bonni 2019). In most cases, however, mutations in epigenetic modifiers result in 6 
up or down regulation of transcription. Indeed, previously identified epigenetic changes in FXS 7 
model mice by Korb et al (2017), particularly H3K4me3, H4K8ac, and H4K16ac, were responsible 8 
for widespread changes in transcription in cortical neurons and the cerebellum. Importantly, these 9 
investigators could rescue several FXS pathophysiologies, many of which resemble those in 10 
autism, by targeting the epigenetic reader protein Brd4. H3K36me3 does not mark promoter 11 
regions, but instead is found in gene bodies and increases as RNA polymerase II proceeds 3’ 12 
during catalysis (Neri et al 2017). In mammals, one of the functions H3K36me3 is correlated with, 13 
if not causative for, alternative pre-mRNA processing (Kim et al 2011). In the Fmr1-deficient 14 
hippocampus, we detected extensive changes in RNA processing, mostly exon skipping. 15 
Surprisingly, most of the skipped exons occurred in genes that have pre-synaptic functions such 16 
as synaptic vesicle recycling, transport, exocytosis, etc., which could at least partially explain 17 
alterations in synaptic vesicle dynamics and neurotransmitter release in FXS model mice (Deng 18 
et al 2013; Ferron et al 2014; Broek et al 2016). Furthermore, a number of skipped exons in Fmr1 19 
KO have been linked to neurological disorders such as Alzheimer’s disease (skipped exon 7 in 20 
APP (Fragkouli et al., 2017; Rockenstein et al., 1995)), Parkinson’s disease (skipped exon 3 in 21 
Mapt (Lai et al., 2017)), and intellectual disabilities (skipped exon12 in Cnksr2 (Houge et al., 22 
2012)).  23 
 Alternative pre-mRNA processing is a common feature in autism (Quesnel-Vallieres et al 24 
2019), so it is perhaps not surprising that this would occur in Fragile X. However, because FMRP 25 
is an RNA binding protein that regulates translation, a reasonable assumption would be that 26 
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17 
mRNAs encoding splicing factors are improperly expressed in the disorder, and that this leads 1 
directly to misplicing events. However, our data indicate that this relationship might not be linear. 2 
Instead, we find that FMRP controls ribosome dynamics on specific mRNAs, which leads to 3 
elevated translation (e.g., SETD2), which leads to chromatin modifications (e.g., H3K36me3), 4 
which in turn might lead to alternative splicing of neuronal mRNAs (Figure 7G). These 5 
observations do not preclude the possible, if not likely, direct involvement of FMRP in some of 6 
these events. Even so, inferences that Fragile X is a disorder of improper translation, while not 7 
incorrect, is vastly oversimplified. However, the complexity of gene expression changes in Fragile 8 
X might offer opportunities for therapeutic intervention at multiple steps. 9 
  10 
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18 
MATERIAL AND METHODS 1 
Mouse acute brain slice preparation 2 
Mouse protocols were reviewed and approved by the institutional animal care and use committee 3 
(IACUC) and all colonies were maintained following animal research guidelines. Transverse 4 
hippocampal or hippocampal-cortical brain slices  were acutely prepared from P28-35 C57BL/6N 5 
wild-type or Fmr1 KO male mice littermates as previously described (Guo et al., 2016). Briefly, 6 
mice were anesthetized with ketamine (125 mg/kg)/xylazine (25 mg/kg) and transcardially 7 
perfused with chilled (4°C) sucrose dissection buffer containing the following (in mM): 2.6 KCl, 8 
1.25 NaH2PO4, 26 NaHCO3, 0.5 CaCl2, 5 MgCl2, 212 mM sucrose, and 10 dextrose aerated with 9 
95% O2/5% CO2. Transverse hippocampal slices (400µm) were obtained on a Leica VT1200S 10 
slicer. For ribosomal profiling experiments (Figure 1), CA3 was cut off to enrich for CA1 and for 11 
each biological replicate, 8-10 slices from 6-8 mice/genotype were pooled. Slices were recovered 12 
and maintained at 30°C for 3-4 hours in artificial cerebrospinal fluid (ACSF) which contained the 13 
following (in mM): 119 NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2, 26 NaHCO3, 1 NaH2PO4 and 11 D-glucose 14 
aerated with 95%/O2/5% CO2 to pH 7.4. Slices were then treated with cycloheximide (100 µg/ml) 15 
in ACSF, 4°C, snap-frozen on dry ice/EtOH bath, and stored at -80°C. For homoharringtonine 16 
(HHT) experiments (Figures 3-5), cortical-hippocampal slices were recovered 3-4 hours in ACSF 17 
and then treated with HHT (20 µM) (Tocris) or 0.05% DMSO (vehicle) for different times (0, 5, 10, 18 
30, 60 min). At the end of the incubation time, slices were snap/frozen on dry ice/EtOH bath and 19 
stored at -80 C. Ten slices from 2-3 mice/genotype were pooled for each biological replicate. 20 
 21 
Sucrose gradients of hippocampal slices for steady-state ribosome profiling 22 
Frozen, isolated CA1 hippocampal slices were thawed in ice-cold homogenization buffer (20mM 23 
Tris-HCl pH7.4, 5mM MgCl2, 100mM KCl, 1mM DTT, 100μg/ml CHX (cycloheximide), 25U/ml 24 
Turbo DNaseI (Ambion, #AM2238), 1X EDTA-free protease inhibitor (Roche), avoiding detergent 25 
in nuclease-free water) on ice for 5min. Wide orifice tips were used to transfer slices to a pre-26 
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19 
chilled detergent-free Dounce homogenizer. Tissues were slowly homogenized by hand (20 1 
strokes of loose pestle A, and 20 strokes of tight pestle B). Homogenates were carefully 2 
transferred to clean 1.5ml tubes with clean glass Pasteur pipets and bulbs. 1% NP-40 was added 3 
to the homogenates and incubated on ice for 10min. Homogenates were clarified by centrifugation 4 
at 2,000g 4 °C for 10min. The supernatants were collected and clarified again by centrifugation 5 
at 20,000g 4 °C for 10min. The supernatants were collected, and the amounts of nucleic acid 6 
were measured by Nanodrop (A260 units). For each sample, cytoplasmic RNA for RNA-seq was 7 
purified from one-fourth of the lysate with TRIzol LS reagent (Invitrogen, #10296028). The other 8 
three-fourths of the lysate was digested with 100ng RNase A (Sigma, # R4875) and 60U RNase 9 
T1 (Thermo Fisher Scientific, #EN0542) per A260 at 25°C for 30 min and stopped by chilling on 10 
ice and adding 50U SUPERase In RNase inhibitor (Ambion, #AM2694). Digested lysates were 11 
applied to 10%-50% (w/v) sucrose gradients prepared in 1X polysome buffer (20mM Tris-HCl 12 
pH7.4, 5mM MgCl2, 100mM KCl, 1mM DTT, 100μg/ml CHX in nuclease-free water). After the 13 
ultracentrifugation in a SW41Ti rotor (Beckman Coulter) at 35,000 rpm (avg 151,263g) 4°C for 14 
2.5 hours, gradients were fractionated at 1.5 ml/min and 12 sec collection intervals through a 15 
fractionation system (Brandel) that continually monitored A260 values. Monosome fractions were 16 
identified, pooled, and extracted with TRIzol LS. 17 
 18 
Sucrose gradients of cortical-hippocampal slices for run-off ribosome profiling 19 
Frozen cortical-hippocampal slices were thawed in ice-cold lysis buffer (20mM Tris-HCl pH7.4, 20 
5mM MgCl2, 100mM KCl, 1mM DTT, 100μg/ml CHX, 25U/ml Turbo DNaseI, 1X EDTA-free 21 
protease inhibitor, 1% NP-40, in nuclease-free water) on ice for 5min. Tissues were dissociated 22 
by pipetting and further trituration through 25G needle for 10 times. Lysates were incubated on 23 
ice for 10min and then clarified by centrifugation at 2,000g 4 °C for 10min. The supernatants were 24 
collected and clarified again by centrifugation at 20,000g 4 °C for 10min. The supernatants were 25 
collected, and the amounts of nucleic acid were measured with Qubit HS RNA assays. Lysates 26 
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20 
containing ~40µg RNA were digested with 600ng RNase A (Ambion, #AM2270) + 75U RNase T1 1 
(Thermo Fisher Scientific, #EN0542) /µg RNA in 0.3ml at 25°C for 30min and stopped by chilling 2 
on ice and adding 50U SUPERase In RNase inhibitor. Digested lysates were applied to 10%-50% 3 
(w/v) sucrose gradients similarly as above. 4 
 5 
Sucrose gradients of cortical-hippocampal slices for polysome profiling 6 
Frozen cortical-hippocampal slices were thawed in ice-cold homogenization buffer on ice for 5min. 7 
Wide orifice tips were used to transfer slices to a pre-chilled detergent-free Dounce homogenizer. 8 
Tissues were gently homogenized by hand (3 strokes of loose pestle A, and 7 strokes of tight 9 
pestle B). Homogenates were carefully transferred to clean 1.5ml tubes with clean glass Pasteur 10 
pipets and bulbs. Homogenates were clarified by centrifugation at 2,000g 4 °C for 10min. The 11 
supernatants were collected and clarified again by centrifugation at 10,000g 4 °C for 10min. The 12 
supernatants were collected, and the amounts of nucleic acid were measured with Nanodrop (A260 13 
units). 1% NP-40 was added to the homogenates and incubated on ice for 10min. ~1A260 unit of 14 
lysate was saved for the input RNA. ~5 A260 units of lysate were applied to 15%-45% (w/w) 15 
sucrose gradients prepared in 1X polysome buffer and with the lower block mark and long cap. 16 
After the ultracentrifugation in a SW41Ti rotor (Beckman Coulter) at 35,000 rpm (avg 151,263g) 17 
4°C for 2 hours, gradients were fractionated at 1.5 ml/min and 20 sec collection intervals through 18 
a fractionation system (Brandel) that continually monitored A260 values. Some gradients were 19 
treated with RNase A prior to centrifugation. 20 
 21 
Ribosome profiling 22 
Ribosome profiling libraries were prepared following the published protocols (Heyer et al., 2015). 23 
Briefly, rRNA was depleted from the purified monosomal RNA with RiboZero (Illumina, 24 
#MRZG12324). Remaining RNA samples were separated on a 15% TBU gel (National 25 
Diagnostics, #EC-833) and the ribosome footprints were size-selected between the 26 and 34nt 26 
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21 
markers. RNA was eluted from the crushed gel pieces in RNA elution buffer (300mM NaOAc 1 
pH5.5, 1mM EDTA, 0.25% SDS) at room temperature overnight, filtered with Spin-X Centrifuge 2 
Tube Filters (Corning, #8162) and precipitated with equal volume of isopropanol. Recovered RNA 3 
was dephosphorylated with T4 Polynucleotide Kinase (NEB, #M0201S) and ligated with 4 
preadenylated adaptor in miRCat®-33 Conversion Oligos Pack (IDT) using T4RNL2Tr.K227Q 5 
ligase (NEB, #M0351L). Reverse transcription (RT) was performed with primers containing 5nt-6 
barcodes and 8nt-unique molecular identifiers (UMIs) and SuperScript III (Invitrogen, #18080-7 
044) in 1X first-strand buffer without MgCl2 (50 mM Tris-HCl, pH 8.3, 75 mM KCl). RT products 8 
were separated on a 10% TBU gel and the 130-140nt region was selected. cDNA was eluted in 9 
DNA elution buffer (10mM Tris pH 8.0, 300mM NaCl, 1mM EDTA) at room temperature overnight, 10 
filtered, and precipitated with isopropanol. Purified cDNA was circularized with CircLigase 11 
(Epicentre, #CL4115K). Except for the RNase titration samples, cDNA derived from remaining 12 
rRNA was hybridized to biotin-labelled antisense probes (IDT) and further depleted with 13 
Dynabeads MyOne Streptavidin C1 (Invitrogen, #65001). Optimal PCR cycle number was 14 
determined empirically by test PCR reactions with titrated cycle numbers. Final PCR amplification 15 
was performed with KAPA Library Amplification Kit (Kapa Biosystems, #KK2611) and 180-190bp 16 
products were size-selected on an 8% TBE gel. DNA was eluted in DNA elution buffer, filtered, 17 
and precipitated with isopropanol. The final library DNA was purified with AMPure XP beads 18 
(Beckman Coulter, #A63880). Oligos used for the library preparation are listed in Table S2. 19 
In parallel, input RNA samples were processed similarly as the ribosome footprints except 20 
the following steps. After rRNA depletion, input RNA mixed with an equal volume of 2x alkaline 21 
fragmentation solution (2 mM EDTA, 10 mM Na2CO3, 90 mM NaHCO3, pH ~ 9.3) and heated at 22 
95°C for 15min to achieve an average fragment length of ~140nt. Fragmented RNA samples were 23 
separated on a 10% TBU gel and size-selected between the 100 and 150nt markers. RT products 24 
were separated on a 10% TBU gel and the 200-250nt region was selected. Antisense probe 25 
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22 
depletion was omitted for input RNA samples. 260-300bp final PCR products were size-selected 1 
on an 8% TBE gel. 2 
The size distributions of final libraries were measured by Fragment Analyzer (Advanced 3 
Analytical, performed by Molecular Biology Core Labs at UMMS). The concentrations were 4 
quantified with KAPA Library Quantification Kit (Kapa Biosystems, #KK4835). Libraries were 5 
pooled with equal molar ratios, denatured, diluted, and sequenced with NextSeq 500/550 High 6 
Output Kit v2 (Illumina, 75bp single-end runs, #FC-404-2005) on a Nextseq500 sequencer 7 
(Illumina). 8 
 9 
RNA-seq for polysome fractions 10 
Based on the FMRP signals in the immunoblotting of gradient fractions, medium and heavy 11 
fractions were identified, pooled, and extracted with TRIzol LS together with saved input lysates. 12 
RNA samples were quantified with Qubit HS RNA assay kit and the integrity was examined with 13 
Fragment Analyzer. 200ng RNA was used for BIOO Rapid directional qRNA-seq library 14 
preparation following the manufacturer’s instructions. 12 cycles were used for the final PCR 15 
amplification. The libraries were quantified with KAPA Library Quantification Kit and the quality 16 
was examined with Fragment Analyzer. Libraries were pooled with equal molar ratios, denatured, 17 
diluted, and sequenced with NextSeq 500/550 High Output Kit v2 (Illumina, 80bp pair-end runs 18 
for RNA-seq, #FC-404-2002) on a Nextseq500 sequencer (Illumina). 19 
 20 
Ribosome profiling read mapping 21 
Individual samples were separated from the raw fastq files based on the barcode sequences. 22 
Adaptor sequences 23 
(TGGAATTCTCGGGTGCCAAGGAGATCGGAAGAGCGGTTCAGCAGGAATGCCGAGACCG) 24 
were removed with cutadapt (1.7.1). Trimmed fastq files were uploaded to the Dolphin platform 25 
(https://www.umassmed.edu/biocore/introducing-dolphin/) at the UMMS Bioinformatics Core for 26 
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23 
the mapping steps. Trimmed reads were quality filtered with Trimmomatic (0.32) and mapped to 1 
the mouse rRNA and then tRNA references with Bowtie2 (2.1.0). Unmapped reads were next 2 
mapped to the mm10 mouse genome with Tophat2 (2.0.9). Reads mapped to >1 loci of the 3 
genome were classified as “multimapped” reads and discarded. PCR duplicates were marked 4 
based on the UMI sequences with custom scripts and only uniquely mapped reads without 5 
duplicates were retained with Samtools (0.0.19) for the downstream analyses. RPF length 6 
distribution, P-site offsets, and frame preference were calculated with plastid (0.4.8). Counts at 7 
each nucleotide position were extracted using P-sites of RPFs and 5’end of mRNA reads with 8 
+11 offset, normalized to the library size, averaged across replicates, and plotted along mRNA 9 
positions with custom scripts. 10 
 11 
Steady-state differential translation analysis 12 
Cleaned bam files were converted to fastq files with bedtools. For both ribosome profiling and 13 
RNA-seq, gene expression was quantified with RSEM (1.2.11) using the cleaned fastq files and 14 
Refseq (V69) mouse CDS without the first and last 30nt to avoid the translation initiation and 15 
termination peaks. Genes were filtered with minimum 10 reads across all replicates and then the 16 
read counts were batch-corrected with the Combat function in sva (3.24.4) using a full model 17 
matrix. Batch-corrected counts were normalized with trimmed mean of M values (TMM) method 18 
and used to identify differential expressed genes (DEGs) with anota2seq (1.0.0). Instead of the 19 
default setting, the priority of TE groups were set to be higher than that of mRNA only groups. A 20 
permutation test was performed to estimate the false discovery rate (FDR) with nominal p-value 21 
< 0.01, which was 0.097. GO analysis was performed and plotted with clusterProfiler (3.10.1) 22 
using all genes past filtering in the dataset as the background. 23 
 24 
Hierarchical clustering of ribosome run-off and gene ontology (GO) enrichment of each 25 
cluster 26 
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24 
To categorize and group genes with distinct ribosome run-off patterns, the RPF of each gene at 1 
each time point was first normalized to time point 0. The Euclidean distance matrix was then 2 
calculated, followed by hierarchical clustering using Ward’s agglomeration method (Ward, 1963). 3 
The clustering process was performed using the hclust (Galili, 2015), and the clustering heatmap 4 
was displayed using pheatmap (Kolde and Kolde, 2015) in R. To test the reliability of clustering, 5 
analysis of group similarities (ANOSIM) test (Clarke, 1993) was performed using vegan (Dixon, 6 
2003) in R with 1000 permutation times on both overall clusters and sub-clusters. The global 7 
pattern of each cluster was summarized using the corresponding median and standard deviation 8 
in each timepoint.   9 
GO enrichment analysis for each sub-cluster were performed through clusterProfiler (Yu 10 
et al., 2012) using genes covered by run-off ribosome profiling as background. The statistical 11 
significance was adjusted using FDR. To remove redundancy in reporting, each reported GO term 12 
was required to have at least 25% of genes that were not associated to another term with a more 13 
significant p value. 14 
Western blotting 15 
Hippocampi were homogenized at 4°C in RIPA buffer. Protein complexes were released by 16 
sonication at 4°C and the extract was centrifuged at 13,200 rpm for 10 min at 4°C and the 17 
supernatant collected. Protein concentration was determined by BCA reagent. Proteins (10 μg) 18 
were diluted in SDS-bromophenol blue reducing buffer with 40 mM DTT and analyzed using 19 
western blotting with the following antibodies: SETD2 (ABclonal, A11271) and Lamin AC (Thermo 20 
Fisher, 14-9688-80). After incubation in primary antibody, immunoblots were incubated with HRP-21 
conjugated secondary antibodies (Jackson Immunoresearch) and developed by Clarity ECL 22 
substrate (Biorad). For sucrose gradient fractions, 60µl samples were mixed with 20µl 4X SDS 23 
loading dye (240mM Tris-HCl pH 6.8, 5% beta-mercaptoethanol, 8% SDS, 40% glycerol, 0.04% 24 
bromophenol blue) and boiled at 95°C for 10min. Samples were briefly heated at 95°C again for 25 
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25 
30sec immediately before loading on 10% SDS-PAGE gel (35 µl/sample). Separated proteins 1 
were transferred to PVDF membranes at constant 90 mA 4°C for 16 hours. Membranes were 2 
blocked with 5% non-fat milk in 1X TBST at room temperature for 1hour and incubated with 3 
primary antibody at 4°C overnight. FMRP (Abcam, 1: 2000), Tubulin (Sigma, 1:5000), Rpl4 4 
(Proteintech, 1:5000), UPF1 (Abcam, 1: 5000), MAP2 (Millipore, 1:2000), eEF2 (Cell signaling, 5 
1:2000), GAPDH (Cell signaling, 1:2000), MRPS18B (Proteintech, 1:2000) and Rps6 (Cell 6 
signaling, 1:4000) were diluted in 1X TBST with 5% non-fat milk. Membranes were washed three 7 
times for 10min with 1XTBST and incubated with anti-rabbit or anti-mouse secondary antibodies 8 
(Jackson, 1:10000) at room temperature for 1hour. Membranes were washed three times for 9 
10min with 1XTBST, developed with ECL-Plus (Piece), and scanned with GE Amersham Imager 10 
Chromatin immunoprecipitation Sequencing (ChIP-Seq) 11 
ChIP was performed as previously described (Cotney and Noonan, 2015). Briefly, 12 
hippocampal tissue was isolated from 4 adult mice (P35) per genotype and minced into tissue < 13 
0.5mm3 in 250ul of ice-cold PBS with protease inhibitors. Tissue was cross-linked with 1% 14 
formaldehyde and rotated at room temperature for 15 min at 50 rpm and quenched with 150mm 15 
glycine for 10 min in a total volume of 1ml PBS. The supernatant was discarded after 16 
centrifugation at 2000g for 10 min at 40C and the pellet was resuspended in 300ul of chilled cell 17 
lysis buffer for 20 min on ice. Swollen pellets were homogenized using a glass Dounce 18 
homogenizer (2ml) with 40 strokes of a tight pestle on ice. Nuclei were harvested after 19 
centrifugation at 2000g for 5min at 40C and resuspended in 300ul ice-cold nuclear lysis buffer for 20 
20min on ice. SDS was added to make a final concentration of 0.5%. Samples were sonicated on 21 
a Bioruptor® sonicator at high power settings for 9 cycles (sonication: 30 sec on, 90 sec off) of 22 
15min each at 4°C at high power. Supernatants were collected after centrifugation at 16,000g for 23 
10 min at 40C. The samples were diluted to bring the SDS concentration <0.1%; 10% of each 24 
sample was reserved as input. The rest of the samples were divided into two and incubated with 25 
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Protein G dynabeads coupled overnight at 40C with either H3K36me3 (Abcam ab9050, 5μg per 1 
ChIP) or IgG (Sigma 12-371, 5 μg per ChIP). After IP, beads were washed, and chromatin eluted 2 
in elution buffer for 20 min shaking at 65°C. IP and Input samples were de-crosslinked overnight 3 
at 65°C. RNAse digestion for 1 hr. at 37°C and proteinase K treatment for 30 min at 55°C was 4 
performed. DNA was then purified with the QIAGEN PCR purification kit in 50ul elution buffer. For 5 
library preparation, purified input and IP DNA was end repaired using T4 DNA polymerase, 6 
Klenow polymerase and T4 Polynucleotide kinase from NEB at 20°C for 30 min. DNA was 7 
extracted using 35ul of the Agencourt Ampure XP beads and ‘A’ bases were added to the 3’ end 8 
using Klenow exonuclease (3’ to 5’ exo minus) from NEB for 30min at 37°C. DNA was purified 9 
using 60ul of the Agencourt Ampure XP beads and Illumina adapter sequences were ligated to 10 
the DNA fragments using the Quick Ligase (NEB) for 15min at 20°C. The library was size-selected 11 
using 50ul of Agencourt Ampure XP beads. Using the multiplexing barcoded primers, the library 12 
was PCR amplified and purified using 50ul of the Agencourt Ampure XP beads and analyzed 13 
using a Fragment Analyzer (Advanced Analytical, performed by Molecular Biology Core Labs at 14 
UMMS). Libraries were pooled with equal molar ratios, denatured, diluted, and sequenced with 15 
NextSeq 500/550 High Output Kit v2.5 (Illumina, 75bp paired-end runs,) on a Nextseq500 16 
sequencer (Illumina). 17 
 18 
ChIP-Seq analysis 19 
For ChIP-sequencing analysis, alignments were performed with Bowtie2 (2.1.0) using the mm10 20 
genome, duplicates were removed with Picard and TDF files for IGV viewing were generated 21 
using a ChIP-seq pipeline from DolphinNext (Yukselen et al., 2019). The broad peaks for 22 
H3K36me3 ChIP-Seq were called using the SICER v1.1 package (Xu et al., 2014). H3K36me3 23 
enriched islands were identified using the parameters set to a window size of 200bp, gap size 24 
600bp and FDR cutoff of 1 × 10-3, and the default value for the redundant rate cutoff. Significantly 25 
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enriched islands for each genotype were identified using the sicer-df.sh script with an FDR cutoff 1 
of 1 × 10-3. Gene Ontology (GO) enrichment analysis was performed using the clusterProfiler 2 
package (Yu et al., 2012) to obtain GO terms related to Biological processes in the genes with 3 
differentially enriched islands in the Fmr1 KO vs Wild type. deepTools was used to plot heatmaps 4 
and profiles for genic distribution of H3K36me3 ChIP signal. Samtools (0.1.19) was used for 5 
sorting and converting Bam files. RPGC (per bin) = number of reads per bin / scaling factor for 1x 6 
average coverage was used for normalization where the scaling factor was determined using 7 
sequencing depth: (total number of mapped reads x fragment length) / effective genome size. 8 
IGV tools (2.3.67) was used for visualizing TDF files and all tracks shown are normalized for total 9 
read coverage.  To quantify the H3K36me3 level for each gene, we calculated ChIP reads density 10 
in TSS regions divided by the corresponding value in the gene body. To quantify the H3K36me3 11 
level at the 5’ and 3’ splicing sites of the SE, the read density of ±50bp at each splice site was 12 
normalized to the read density in the entire gene body, which controls for any fluctuations in total 13 
H3K36me3 at the respective genes between both genotypes. 14 
 15 
Alternative splicing analysis 16 
RNA-seq from hippocampal slices was used to analyze alternative splicing (AS) using the rMATS 17 
package v3.2.5 (Shen et al., 2014) with default parameters and reads were trimmed to 50bp. The 18 
Percent Spliced In (PSI) levels or the exon inclusion levels calculated by rMATS using a 19 
hierarchical framework. To calculate the difference in PSI between genotypes a likelihood-ratio 20 
test was used. AS events with an FDR < 5% and |deltaPSI| ≥ 5% as identified using rMATS were 21 
used for further analysis. We included genes that had at least one read at the differential splice 22 
junction for both genotypes. GO enrichment analysis was done by the clusterProfiler package (Yu 23 
et al., 2012) to obtain GO term enrichment for the AS events. The genes with significant skipped 24 
exons were used for validation using RT-qPCR analysis. One ug of RNA from hippocampal tissue 25 
was used to generate cDNA using the Quantitech two-step cDNA synthesis kit. Primers were 26 
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designed to overlap skipped/inclusion exon junctions and qPCR was performed using the Bio-1 
Rad SYBR reagent on a Quantstudio3 instrument.   2 
Quantification and statistical analysis 3 
All grouped data are presented as mean ± s.e.m. Student’s t test was used to determine statistical 4 
significance between groups. The Kolmogorov-Smirnov (K-S) test was used to compare the 5 
distributions in the volcano plots. When exact p values are not indicated, they are represented as 6 
follows: *, p < 0.05; **, p < 0.01; ***, p < 0.001; n.s., p > 0.05. 7 
 8 
Data and software availability 9 
Codes and scripts used for quantification analysis were written in Python or R and will be provided 10 
upon request to the Lead Contact. Data Resources Sequencing datasets generated in this study 11 
have been deposited into the GEO database under the accession number GEO:  12 
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Figure Legends 
Figure 1. Ribosome Profiling Reveals Diverse Changes of Gene Expression in Fmr1 KO 
Hippocampus.  
(A) Schematic diagram of the hippocampal slice preparation. To reduce spontaneous electrical 
activity, region CA3 was excised. 
(B) Schematic diagram of the experimental procedures for ribosome profiling. 
(C) Scatter plot of expression changes of mRNA levels and ribosome protected fragments (RPFs). 
Dysregulated mRNAs in the absence of FMRP are classified into four regulatory groups. 14459 
genes past filtering are used for the scatter plot. Nominal p-value < 0.01, FDR = 0.097 by 
permutation test. FC, fold change. TE, translational efficiency. 
 (D) Top 3 GO terms of Biological Process enriched in each regulatory group. The enrichment 
(gene ratio) is represented by the size of dots. The enrichment significance (adjusted p-value) is 
color coded. 
(E) Top 3 GO terms of Cellular Component enriched in each regulatory group. (also see Figure 
S1, Table S1) 
 
Figure 2. Characterization of Genes with Translational Efficiency Changes in Fmr1 KO 
Hippocampus.  
(A) Heatmap of expression changes (log2FC KO/WT) for the top 20 RNAs in the “TE up” group. 
(B) Heatmap of expression changes (log2FC KO/WT) for the top 20 RNAs in the “TE down” group. 
(C) Read distributions on the Gfpt2 RNA of TE up group. FMRP CLIP tags (top) (Darnell et al 
2011), normalized RPF reads (middle), and mRNA reads (bottom) averaged across all replicates 
are plotted along the mRNA nucleotide positions with green and red triangles for annotated start 
and stop codons respectively. For visualization purposes, the curves were smoothed within a 30nt 
window.  
(D) Read distributions on the Lhfpl2 RNA of TE down group. 
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(E) Boxplots visualize the medians of expression changes for FMRP CLIP targets. The lower and 
upper hinges correspond to the first and third quartiles. The whiskers extend from the hinges to 
the largest and smallest values no further than 1.5 fold of inter-quartile range. Outliers are not 
shown. Gene expression changes of CLIP genes were compared to those of all genes used for 
DEG analysis (ns: not significant, **** p-value <0.0001, Wilcoxon rank sum test after multiple test 
correction with the Bonferroni method). CLIP genes are the FMRP targets identified in (Darnell et 
al 2011). 
(F) Overlap of the TE down and up genes detected in this study (orange) with those of Das 
Sharma et al (2019 (green) and the TRAP-seq data of Thomson et al (2017) (blue). 
(G) Schematic models of ribosome density (TE) changes that reflect increased protein synthesis 
rates. (also see Table S1) 
 
Figure 3. Run-off ribosome profiling of WT mouse brain slices.  
(A) Schematic diagram of homoharringtonine (HHT) run-off ribosome profiling. WT mouse brain 
splices was treated with 20µM HHT, an inhibitor of translation initiation, to allow ribosome run-off 
for 5, 10, 30, and 60min (t)  at 30°C. 
(B) Metagene plot of RPFs after HHT treatment. Reads are mapped transcripts (N=1401) with 
CDS longer than 3000nt, and aligned at the annotated start and stop codons (grey vertical dash 
lines). The read densities at each nucleotide position are normalized to the average density of the 
last 500nt of CDS and averaged using the P sites of RPFs. For visualization purposes, the curves 
were smoothed within a 90nt window. Black horizontal dash line indicates the arbitrary 0.8 
threshold to estimate the relative run-off distances (black vertical dash lines). 
(C) Linear regression between the HHT treatment time and ribosome run-off distances (from B) 
to estimate the global elongation rate (4.2 nt/sec). 
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(D) Cluster analysis of gene groups with distinct ribosome run-off patterns. The RPFs of each 
gene at each time point was formalized to time 0. The Euclidean distance matrix was then 
calculated, followed by hierarchical clustering using Ward’s agglomeration method (Ward, 1963). 
(E) Ribosome runoff patterns for each sub-cluster. The global pattern of each sub-cluster was 
summarized using the corresponding median and standard deviation in each timepoint. The 
number of RNAs in each sub-cluster is shown in parentheses. 
(F) Representative ribosome runoff profiles that reflect each sub-cluster. The runoff pattern for 
Actin is similar to sub-clusters 4-6. 
(G) Ribosome footprints for Nrxn3 and Actin mRNAs during the runoff time period.  
(H) GO terms for sub-clusters 1 and 3. Gene ratio refers to the percentage of total differentially 
expressed genes in the given GO term. (also see Figure S2, Table S1) 
 
Figure 4. Substantial FMRP remains associated with polysomes after HHT treatment. 
(A-D) WT mouse hippocampal slices were treated with DMSO vehicle (A) or 20µM HHT (B) for 
30min at 30°C. In parallel, Fmr1 KO mouse hippocampal slices were also treated with DMSO 
vehicle (C) or 20µM HHT (D) for 30min at 30°C. Slices were homogenized and applied to 15-45% 
(w/w) sucrose gradients, which were fractionated with continuous monitoring of A260 after the 
ultracentrifugation. Fractions were collected for immunoblotting with indicated antibodies to detect 
the association of FMRP with polysomes. 
(E) RNA sedimenting to “heavy” fractions containing >7 ribosomes from WT slices treated with 
HHT was analyzed relative to input. 1574 RNAs were reduced and 686 were elevated relative to 
input after HHT treatment. 
(F) Actin mRNA reads in the designated conditions (WT, wild type; V, vehicle, I, input; H, heavy 
fractions, KO, Fmr1 KO). 
(G) Map 1b mRNA reads in the designated conditions. 
(H) GO terms of RNAs depleted in heavy fractions relative to WT. 
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(I) GO terms of RNAs enriched in heavy fractions relative to WT. (also see Figure S3, Table S1) 
 
Figure 5. FMRP stalls ribosomes on specific mRNAs.  
(A) RNA sedimenting to “medium” polysomes containing 4-6 ribosomes after HHT treatment of 
hippocampal slices; 46 RNAs are down-regulated and 1 is up-regulated in Fmr1 KO relative to 
WT. 
(B) Down-regulated RNAs in HHT-treated Fmr1 KO slices primarily encode epigenetic and 
transcriptional regulators and proteins involved in neural function. 
(C) Example of Ankrd12 RNA, which has reduced reads in Fmr1 KO slices relative to WT after 
HHT (H) treatment. Input (I) reads are similar in both genotypes. M refers to medium fraction. 
(D) Box plot showing the fold change of Fmr1 KO versus WT of all RNAs (white) compared to 
those identified in Figure 5 A and B (gray) with respect to steady state RNA levels, RPFs, and TE 
(ns: not significant, *p-value <0.01, **p-value <0.001, Wilcoxon rank sum test after multiple test 
correction with the Bonferroni method). 
(E) Western analysis of SETD2 and lamin ac in hippocampus from 4 WT and 5 Fmr1 KO mice. 
When quantified and made relative to Lamin AC, SETD2 was significantly increased in the KO 
(p=0.0245, two-tailed t test). (also see Table S1) 
 
 
Figure 6. H3K36me3 localization is altered in Fmr1 KO hippocampus. 
 (A) Experimental design for in vivo ChIP-seq of H3K36me3 in hippocampus from adult WT (N=4) 
and Fmr1 KO (N=4) mice. 
(B. I) Pie chart representing the genomic annotation of the total H3K36me3 islands identified in 
the WT and Fmr1 KO ChIP-seq. II) Venn diagram illustrating the number of genes with H3K36me3 
islands identified in WT (blue) and Fmr1 KO (green) ChIP-seq in both biological replicates 
combined. 
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(C) H3K36me3 ChIP-seq gene tracks for WT and Fmr1 KO hippocampal tissue. The two 
sequencing tracks from each biological replicate (n=2) of WT and Fmr1 KO were merged and 
overlaid. WT ChIP-seq tracks are in blue and KO tracks are in green. The tracks for IP and input 
are displayed. The island with significantly decreased (blue) or increased (green) tracks are 
shown below the Refseq gene annotation (FDR <0.0001 and p-value <0.01) as identified using 
the SICER package. Reep4 shows decreased H3K36me3 islands in Fmr1 KO and Tprkb shows 
increased islands in Fmr1 KO 
(D) Distribution of significantly increased or decreased H3K36me3 islands as identified by SICER-
df.sh package (FDR<0.0001 and p-value <0.0001) within genes (intragenic) or in gene proximal 
(intergenic) regions. The total number of increased or decreased islands is indicated above the 
respective bars in the graph in Fmr1 KO vs wild type ChIP-seq. 
(E) Venn diagram for significant overlap of Fmr1 KO mis-regulated H3K36me3 genes (increased 
islands in green and decreased islands in blue) with the ASD-linked genes from the SFARI 
database. A subset of genes (219) showed both increased and decreased islands along the 
length of the gene body. The p-value is indicated next to the respective comparisons.  
(F) GO term enrichment of H3K36me3 differentially enriched genes in Fmr1 KO vs WT (p.adjust 
value<0.05). (also see Figure S4, Table S2) 
 
Figure 7. Global analysis of FMRP mediated alternative splicing (AS). 
(A) Summary table of total splicing events in Fmr1 KO and WT based on RNA-seq from 
hippocampal slices. Splicing events detected by rMATS at a FDR < 5% and a difference in the 
exon inclusion levels between the genotypes  (deltaPSI) ≥ 5% are depicted. 
(B) Alternatively spliced events validated using RT-qPCR are shown for several RNAs 
(hippocampus tissue, WT, n=6; Fmr1 KO, n=6). The illustration depicts an example of exon 
skipping (green box) in the Fmr1 KO. Primer positions are depicted with black bars. 
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(C) Alternative splicing events detected in Fmr1 KO and WT hippocampus. Inclusion events that 
were significantly (p-value<0.05) increased (red), decreased (blue), or unchanged (gray) are 
indicated. The number of events in the up or down category are shown in red and blue, 
respectively. PSI, (Percent Splice In / Exon inclusion levels). 
(D) GO term enrichment for all alternative splicing events are shown (p.adjust value <0.05). The 
total number of genes identified in the RNA-seq from (Figure 1) were used as background. 
(E) Table depicting the overlap of the alternatively spliced (Alt. Spl./AS) genes in this study with 
the SFARI Autism Spectrum Disorder database, the Alt. Spl. genes identified in samples from 
autism patients (Parikshak et al., 2016), and genes with increased or decreased H3K36me3 
islands from Figure 6. The intensity of the color represents the increasing number of overlapping 
genes between the gene sets. Asterisks indicate statistical significance. 
(F) Violin plot for the H3K36me3 ChIP signal at the 5’ (SS5) and 3’ (SS3) splice sites of the 
alternatively skipped exons in WT (white) and Fmr1 KO (red) hippocampus tissue (p-value<0.05, 
KS test for significance). 
(G) Model for FMRP mediated alterations in H3K36me3 marks on the chromatin and alternative 
splicing of transcripts in the hippcampus. (also see Table S3) 
 
Figure S1. Clustering of RNAs with changes in TE and mRNA abundance to identify 
functional hubs (Related to Figure 1, also see TableS1) 
(A) Network clustering of “mRNA up” RNAs from the ribosome profiling and RNA-seq in WT and 
Fmr1 KO hippocampus. Nodes indicate the functional processes linked to the RNAs identified. 
Fold changes are indicated.  
(B) Network clustering of the functional processes in the  “mRNA down” RNAs  
(C) Network analysis of the of the functional processes in the  “TE down” mRNAs  
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Figure S2. Run-off ribosome profiling of WT mouse hippocampal slices. (Related to Figure 
3, also see Table S1) 
 (A) Ribosome runoff patterns for clusters 1 and 2. The RPFs of each gene at each time point was 
normalized to time 0. The euclidean distance matrix was then calculated, followed by hierarchical 
clustering using Ward’s agglomeration method (Ward, 1963). The global pattern of each sub-
cluster was summarized using the corresponding median and standard deviation in each 
timepoint. Representative ribosome runoff profiles are shown.  
(B) CDS length dependency of the ribosome runoff rates. Results of the KS test for significance 
are shown  
(C) GO terms for sub-clusters 2,4, 5 and 6. 
 
Figure S3. Sedimentation of proteins in polysome sucrose gradients. (Related to Figure 4, 
also see Table S1) 
(A) Hippocampal extracts, some of which were treated with RNAse A, were centrifuged through 
sucrose gradients, fractionated, and immunoblotted for FMRP, RPS6 and RPL4. Long and short 
refer to relative exposure times. 
(B) Hippocampal slices from WT or FMRP KO mice were treated with vehicle only or HHT for 30 
min. The gradients were fractionated and immunoblotted for the indicated proteins. The red arrow 
denotes the eEF2 band. The medium polysome fractions are indicated. 
 
Figure S4. H3K36me3 ChIP metagene analysis (Related to Figure 6, also see Table S2) 
(A)  Scatter plot for ChIP-seq normalized reads density (Transcripts per million mapped reads, 
TPM) mapped to the genic regions between biological replicate samples, WT1 and WT2 and 
Fmr1 KO1 and Fmr1 KO2. r values for correlation efficiency is shown.  Asterisks indicate statistical 
significance. 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/801076doi: bioRxiv preprint first posted online Oct. 10, 2019; 
46 
 
(B)  Metagene plots using deepTools for distribution of H3K36me3 marks along the gene lengths. 
A similar increase in ChIP signal in all samples is seen in the gene body. The transcription start 
site (TSS), Transcription end site (TES) and 2.0kb downstream is shown. 
(C) Heatmap for distribution of H3K36me3 signal along the gene length in each sample, compiled 
plot in Figure S4B. The transcription start site (TSS), Transcription end site (TES) and 4.0kb 
downstream is shown. No overall differences in ChIP signal was observed between samples. 
(D) Violin plot to assess the effect of gene length on H3K36me3 ChIP signal between WT (white) 
and Fmr1 KO (red) samples.  
(E) Histogram depicting number of islands (log scale) and their respective island length for all 
significant islands (bp in log scale) identified in the WT (blue) and Fmr1 KO (green) ChIP-seq. 
The island lengths were parsed in bins of 100bp and the center of each bin is plotted in the 
histogram. Asterisks indicate statistical significance. 
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